Back
to sessions
Sep 30
Quick Pitch
MODERATOR(S)
Mark Hurwitz, MD, FASTRO - New York Medical College/Westchester Medical Center Health
Martin King, MD, PhD - Brigham and Women's Hopsital
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
10:30am - 10:35am ETSpeaker: Mark Hurwitz, MD, FASTRO - New York Medical College/Westchester Medical Center Health, Valhalla
-
10:35am - 10:40am ET
Impact of Early vs. Delayed All-Site Radiotherapy on Clinical Outcomes in High Gleason Score Metastatic Hormone-Sensitive Prostate Cancer: Results from a Long-Term Study
Speaker: Huizhu Chen, MD - Peking University First Hospital, Beijing -
10:40am - 10:45am ET
Adjuvant Docetaxel Following Radiotherapy Plus Long-Term ADT for Grade Group 5 Non-Metastatic Prostate Cancer: A Prospective, Comparative Cohort Study
Speaker: Mingwei Ma, MD - Peking University First Hospital, Beijing -
10:45am - 10:50am ET
Optimizing Postoperative Radiotherapy Target Volumes in Prostate Cancer Based on PSMA PET Recurrence Mapping
Speaker: Huan Zhang, MD - Peking University First Hospital, Beijing -
10:50am - 10:55am ET
Elective Pelvic Nodal Radiation in Prostate Cancer with and without Mesorectal or Extra-Pelvic Disease
Speaker: Jade Dodge, MS, BS - Drexel University College of Medicine, Philadelphia -
10:55am - 11:00am ET
Timing of GLP-1 Receptor Agonist Initiation and Cardiovascular Events in Men Receiving Androgen Receptor Pathway Inhibitors
Speaker: Nikhil Chakravarty, - Cedars-Sinai Medical Center, Los Angeles -
11:00am - 11:05am ET
PSMA-PET Avidity and Prostate Cancer-Specific Mortality in Men with Gleason =8 Disease Presenting with Very Low PSA Levels
Speaker: Zachary McSween, MD, MS - St. George's University School of Medicine, -
11:05am - 11:25am ETSpeaker: Martin King, MD, PhD - Brigham and Women's Hopsital, Boston
-
11:25am - 11:30am ETSpeaker: Mark Hurwitz, MD, FASTRO - New York Medical College/Westchester Medical Center Health, Valhalla